TCRR
Barclays’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,116
| Closed | -$50K | – | 4577 |
|
|
2023
Q1 | $50K | Hold |
33,116
| – | – | ﹤0.01% | 3792 |
|
|
2022
Q4 | $33K | Sell |
33,116
-445
| -1% | -$443 | ﹤0.01% | 3918 |
|
|
2022
Q3 | $60K | Sell |
33,561
-1,964
| -6% | -$3.51K | ﹤0.01% | 3605 |
|
|
2022
Q2 | $103K | Sell |
35,525
-4,952
| -12% | -$14.4K | ﹤0.01% | 3447 |
|
|
2022
Q1 | $111K | Sell |
40,477
-8,594
| -18% | -$23.6K | ﹤0.01% | 3618 |
|
|
2021
Q4 | $229K | Buy |
49,071
+16,039
| +49% | +$74.8K | ﹤0.01% | 2790 |
|
|
2021
Q3 | $281K | Sell |
33,032
-9,203
| -22% | -$78.3K | ﹤0.01% | 2832 |
|
|
2021
Q2 | $694K | Sell |
42,235
-6,544
| -13% | -$108K | ﹤0.01% | 2309 |
|
|
2021
Q1 | $1.08M | Buy |
48,779
+37,344
| +327% | +$825K | ﹤0.01% | 2257 |
|
|
2020
Q4 | $353K | Sell |
11,435
-3,561
| -24% | -$110K | ﹤0.01% | 2481 |
|
|
2020
Q3 | $304K | Buy |
14,996
+6,027
| +67% | +$122K | ﹤0.01% | 2543 |
|
|
2020
Q2 | $138K | Buy |
8,969
+5,076
| +130% | +$78.1K | ﹤0.01% | 2990 |
|
|
2020
Q1 | $30K | Sell |
3,893
-7,992
| -67% | -$61.6K | ﹤0.01% | 3282 |
|
|
2019
Q4 | $169K | Buy |
11,885
+6,000
| +102% | +$85.3K | ﹤0.01% | 3252 |
|
|
2019
Q3 | $89K | Buy |
5,885
+4,713
| +402% | +$71.3K | ﹤0.01% | 3461 |
|
|
2019
Q2 | $16K | Sell |
1,172
-1,146
| -49% | -$15.6K | ﹤0.01% | 3988 |
|
|
2019
Q1 | $40K | Buy |
+2,318
| New | +$40K | ﹤0.01% | 3739 |
|